搜索临床试验以:CHF6333(第 1 部分 - SAD)
总计434个结果
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ)完全的
-
Sun Pharma Advanced Research Company Limited终止
-
Emory UniversityNational Cancer Institute (NCI); Novartis; Secura Bio, Inc.招聘中
-
AstraZenecaAcerta Pharma, LLC完全的
-
Tetherex Pharmaceuticals Corporation完全的
-
Wake Forest University Health Sciences完全的
-
iN Therapeutics Co., Ltd.招聘中
-
Bilthoven BiologicalsSerum Institute of India Pvt. Ltd.完全的
-
Kanyos Bio, Inc., a wholly-owned subsidiary of...Pfizer招聘中
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); University of Southern California; University of Connecticut; California...完全的
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 乳腺癌 | 卵巢癌 | 胰腺癌 | 前列腺癌 | 复发性乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性 | 三阴性乳腺癌 | 遗传性乳腺癌和卵巢癌综合症 | BRCA1突变携带者 | BRCA2突变携带者 | 实体肿瘤 | Basal-Like Breast Carcinoma美国
-
National Cancer Institute (NCI)完全的
-
Qilu Hospital of Shandong UniversityJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
National Cancer Institute (NCI)NRG Oncology完全的复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | BRCA1突变携带者 | BRCA2突变携带者 | 卵巢上皮性肿瘤美国
-
Janssen Research & Development, LLC完全的
-
Verrica Pharmaceuticals Inc.Instat Clinical Research; HeartcoR Solutions; Myonex; Vial Health Technology, Inc招聘中
-
M.D. Anderson Cancer Center撤销
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin Branch招聘中
-
National Institute of Allergy and Infectious Diseases...完全的
-
Janssen Research & Development, LLC完全的
-
Janssen Research & Development, LLC终止淋巴瘤,滤泡性 | 淋巴瘤,大 B 细胞,弥漫性 | 淋巴瘤,套细胞 | 前体细胞淋巴细胞白血病-淋巴瘤 | 白血病、淋巴细胞性、慢性、B 细胞美国, 法国, 西班牙, 比利时, 以色列
-
Mayo ClinicNational Cancer Institute (NCI)完全的